Medstar Georgetown University Hospital — Washington D.C., District of Columbia

Medstar Georgetown University Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Medstar Georgetown University Hospital has participated in 60 clinical trials with 19 currently active.

Therapeutic areas: Delayed Graft Function, Varicose Veins, Progressive Familial Intrahepatic Cholestasis.

Sponsors: Angion Biomedica Corp, Boston Scientific Corporation, Mirum Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medstar Georgetown University Hospital?

Medstar Georgetown University Hospital has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medstar Georgetown University Hospital conducted?

Medstar Georgetown University Hospital has 60 clinical trials on record, with 19 currently active. Their work covers Delayed Graft Function, Varicose Veins, Progressive Familial Intrahepatic Cholestasis.

Is Medstar Georgetown University Hospital accredited by Crixeo Health?

Medstar Georgetown University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medstar Georgetown University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.